文献速递头颈外科

结外延伸是HPV阳性口咽鳞状细胞癌的强预后因素

Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
PubMed 文献 · Laryngoscope · 2019-05-11

基于美国国家癌症数据库2010至2015年确诊的HPV阳性口咽鳞状细胞癌(OPSCC)回顾性队列,纳入接受手术及颈淋巴结清扫的病例。结外延伸(ENE)阳性者5年生存率84.0%(95%CI 80.7%-87.4%),低于ENE阴性者的92.6%(95%CI 90.5%-94.7%);校正混杂因素后ENE阳性与近乎两倍的死亡风险相关(HR=1.90;95%CI 1.35-2.67)。

要点

  • ENE阴性者5年生存率92.6%(95%CI 90.5%-94.7%),ENE阳性者84.0%(95%CI 80.7%-87.4%)。
  • 校正混杂后,ENE阳性者死亡风险约为ENE阴性者的1.90倍(HR=1.90;95%CI 1.35-2.67)。
  • N2/ENE阳性者较N1/ENE阴性者生存最差(HR=2.93;95%CI 1.94-4.43)。

核心结论

  • 美国癌症联合委员会(AJCC)第8版分期系统为HPV阳性OPSCC治疗计划的制定与讨论提供了大为改进的框架。
  • 作者认为应仔细考虑ENE在HPV阳性OPSCC患者中的重要性。

研究设计与样本

  • 回顾性队列研究,纳入美国国家癌症数据库2010至2015年确诊、具有适当国际疾病分类-0-3编码且接受手术联合颈淋巴结清扫的HPV阳性OPSCC病例。
  • 采用单因素和多因素分析,通过Cox比例风险回归估计ENE与N分期对总生存的独立效应风险比(HR)。
  • 证据等级为4级(Laryngoscope, 130:939-945, 2020)。

主要发现

  • ENE阴性病例5年生存率最高(92.6%;95%CI 90.5%-94.7%),ENE阳性病例5年生存率最低(84.0%;95%CI 80.7%-87.4%)。
  • 校正混杂变量后,ENE阳性者死亡风险约为ENE阴性者的1.90倍(HR=1.90;95%CI 1.35-2.67)。
  • 在N1类别中,ENE阳性者较N1且ENE阴性者死亡风险升高(HR=1.88;95%CI 1.26-2.80)。
  • 与N1/ENE阴性病例相比,N2/ENE阳性病例生存最差(HR=2.93;95%CI 1.94-4.43)。
  • 与淋巴结阳性且ENE阴性状态相比,显微镜下和宏观ENE均与更差结局相关。

临床怎么用

  • 作者认为应仔细考虑ENE在HPV阳性OPSCC患者中的重要性。
  • 作者认为AJCC第8版分期系统为HPV阳性OPSCC治疗计划的制定与讨论提供了大为改进的框架。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To comprehensively examine the prognostic significance of extranodal extension (ENE) in human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV-positive OPSCC). METHODS: Retrospective cohort of cases diagnosed with HPV-positive OPSCC from 2010 to 2015 in the National Cancer Database. Inclusion of all OPSCC HPV-positive cases with appropriate International Classification of Diseases-0-3 codes that received surgery with a neck dissection. Univariate and multivariable analyses were conducted. Hazard ratios (HR) for the independent effects of ENE and N stage on overall survival were estimated by Cox proportional hazards regression. RESULTS: Cases that were ENE-negative had the highest 5-year survival (92.6%; 95% confidence interval [CI]: 90.5%-94.7%). ENE-positive cases had the lowest 5-year survival (84.0%; 95% CI: 80.7%-87.4%). After adjusting for confounding variables, ENE-positivity was associated with almost twice the hazard of death (HR = 1.90; 95% CI: 1.35-2.67) compared to ENE-negative cases. Nodal (N) category 1, ENE-positive status was associated with an increased risk of death (HR = 1.88; 95% CI: 1.26-2.80) compared with N1, ENE-negative status. Compared to N1/ENE-negative cases, N2/ENE-positive cases had the poorest survival (HR: 2.93; 95% CI: 1.94-4.43). Both microscopic and macroscopic ENE were associated with worse outcomes compared to node-positive/ENE-negative status. CONCLUSION: The implementation of the American Joint Committee on Cancer 8th edition staging system provides a much-improved framework to develop and discuss treatment plans for HPV-positive OPSCC. We feel that careful consideration should be given to the importance of ENE in patients with HPV-positive OPSCC. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:939-945, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Bauer E, Mazul A, Chernock R, et al. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma. Laryngoscope. 2019. PMID: 31077394. doi:10.1002/lary.28059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。